Original news and analysis on international IP policy
The invitation by the South African Department of Trade and Industry (DTI) to intellectual property stakeholders to comment on its recently released IP Consultative Framework has reignited calls for the department to come clean on the status of the national draft IP policy.
Gavi, the vaccine alliance, announced yesterday that a UNICEF pentavalent vaccine tender will secure sufficient supplies for the next three years to protect millions of children in Gavi-supported and transitioning countries.
Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.
Nearly 100 health, community and development organisations working in the Asia-Pacific region issued a call for trade ministers negotiating the Regional Comprehensive Economic Partnership (RCEP) trade agreement to "reject provisions that would negatively affect access to generic medicines." Negotiators are meeting from 17-22 October in China, and the concern is about the intellectual property chapter of the deal.
Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.
The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.
A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.
The term “Open” in science is all the rage these days.
A new database was launched this week to facilitate navigation through the patent field and increase transparency surrounding the patent status of medicines and licences.
As autumn rolled in, two United Nations agencies chose global figures to help them with their missions, another has a new website, and changed heads, while non-governmental organisations, law offices, and industry also saw numerous changes at management level.
Following a public hearing at its headquarters in Munich, the European Patent Office (EPO) decided to reject in part the arguments made by Gilead Sciences to uphold their patent on sofosbuvir, according to a non-profit group.
Initiating a new partnership today, global health initiative UNITAID and the non-profit FIND began a project that will work towards the improvement, affordability and availability of diagnostics and treatments for the hepatitis C virus (HCV).